White Fund

White Fund is a venture capital firm based in Liège, Belgium, established in 2019, that specializes in early-stage investments in the medical device and medtech sectors. The firm focuses on companies that have demonstrated a proof of concept for their technology and have shown objective market traction. White Fund primarily targets investments within Belgium but may consider opportunities in neighboring regions. It typically invests between €2 million and €3 million in each project, spanning two to three rounds of financing, with an exit strategy aimed at five to seven years. The firm is dedicated to supporting the pre-marketing stages and the launch of sales for innovative healthcare solutions, including prevention, diagnostic, monitoring, and treatment technologies.

Michel Baijot

Chairman

Benoit Fellin

Fund Director

Joanna Tyrekidis

Co-Founder

11 past transactions

Minze Health

Series A in 2024
Founded in Belgium in 2015, Minze Health specializes in digital health solutions for urinary tract problems. Its remote patient monitoring systems are used globally by hospitals and urology practices.

Clouds of Care

Venture Round in 2024
Clouds of Care specializes in assisting HealthTech firms navigate algorithm validation to medical device software, with a focus on ensuring regulatory compliance.

neuroClues

Seed Round in 2024
neuroClues develops AI-driven eye-tracking technology for clinical use that quantifies neurological function during exams. The platform provides an easy-to-use eye-tracking environment enabling clinicians to assess brain health non-invasively and monitor neurological conditions. By applying AI to eye movement data, the company aims to enable earlier detection of neurological disorders such as Parkinson's and Alzheimer's disease, potentially improving patient outcomes and informing treatment decisions. The approach offers a non-invasive diagnostic aid that can complement traditional assessments and support streamlined clinical workflows.

Axithra

Seed Round in 2023
Axithra specializes in therapeutic medication monitoring, specifically focusing on measuring beta-lactam antibiotic concentrations in blood. Its proprietary platform enables personalized treatments by accurately determining drug concentrations, optimizing patient care.

Minze Health

Seed Round in 2022
Founded in Belgium in 2015, Minze Health specializes in digital health solutions for urinary tract problems. Its remote patient monitoring systems are used globally by hospitals and urology practices.

Intressa Vascular

Funding Round in 2022
Intressa Vascular specializes in cardiovascular solutions, focusing on treating aortic dissections. They offer endovascular treatments using their proprietary braiding technology platform and procedure planning services to enhance patient care.

Bingli

Series A in 2022
Bingli is a healthcare technology company that specializes in developing applications aimed at improving communication between patients and doctors. The company's application conducts smart pre-consultation interviews with patients, enabling them to accurately convey their symptoms to healthcare providers. This process ensures that patients are better prepared for their consultations, while also allowing doctors to save time during appointments. By facilitating more effective information sharing, Bingli aims to enhance the overall quality of healthcare delivery.

moveUP

Seed Round in 2021
moveUP develops digital therapeutics solutions, focusing on improving patient engagement and streamlining healthcare delivery. Its closed-loop system ensures high compliance and better outcomes by continuously collecting data to personalize treatment. Currently, it offers a therapy for orthopaedic patients undergoing joint surgery, with CE medical device certification.

Endo Tools Therapeutics

Series D in 2021
Endo Tools Therapeutics is a medical device company focused on gastroenterology, developing and manufacturing therapeutic devices and the ENDOMINA open platform that supports therapeutic endoscopic procedures. Founded in 2008 and based in Belgium, the company develops catheters with therapeutic channels and increased degrees of freedom for interventional gastro-enterology, as well as tools for endoscopic suturing and tissue apposition. Its devices aim to treat obesity, digestive tract tumors, and diabetes by enabling minimally invasive surgical endoscopy.

Antelope Dx

Series B in 2020
Antelope Dx BV is a Belgian company founded in 2018, focused on developing innovative diagnostic solutions for home testing and point-of-care applications. The company has created a palm-sized diagnostic device that utilizes lab-on-chip technology, allowing users to conduct high-quality tests on various bodily fluids without the need for complex procedures or sample preparation. Among its offerings is the Antelope Diagnostic STD-Test, a urine-based self-test for detecting common sexually transmitted diseases, including Chlamydia trachomatis and Neisseria gonorrhoeae. Antelope Dx aims to enhance accessibility to essential health diagnostics for consumers, healthcare professionals, and sectors such as animal health and drug development. Based in Zwijnaarde, Belgium, the company is committed to advancing the field of diagnostics through user-friendly and effective testing solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.